4.5 Review

Asymmetric Dimethylarginine (ADMA) in Pediatric Renal Diseases: From Pathophysiological Phenomenon to Clinical Biomarker and Beyond

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Regulation of Nitric Oxide Production in the Developmental Programming of Hypertension and Kidney Disease

Chien-Ning Hsu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Biochemistry & Molecular Biology

The Association between Nitric Oxide Pathway, Blood Pressure Abnormalities, and Cardiovascular Risk Profile in Pediatric Chronic Kidney Disease

Chien-Ning Hsu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Immunology

Asymmetric dimethylarginine is not a marker of arterial damage in children with glomerular kidney diseases

Piotr Skrzypczyk et al.

CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2019)

Review Biochemistry & Molecular Biology

Biochemistry and regulation of the protein arginine methyltransferases (PRMTs)

Yalemi Morales et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2016)

Article Peripheral Vascular Disease

Low urinary citrulline/arginine ratio associated with blood pressure abnormalities and arterial stiffness in childhood chronic kidney disease

I-Chun Lin et al.

JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2016)

Article Multidisciplinary Sciences

Effects of ADMA on gene expression and metabolism in serum-starved LoVo cells

Ningning Zheng et al.

SCIENTIFIC REPORTS (2016)

Review Biochemistry & Molecular Biology

Targeting on Asymmetric Dimethylarginine-Related Nitric Oxide-Reactive Oxygen Species Imbalance to Reprogram the Development of Hypertension

You-Lin Tain et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Article Biochemistry & Molecular Biology

Renal Transcriptome Analysis of Programmed Hypertension Induced by Maternal Nutritional Insults

You-Lin Tain et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

Article Biochemistry & Molecular Biology

Transcriptome Analysis in Rat Kidneys: Importance of Genes Involved in Programmed Hypertension

You-Lin Tain et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

Article Medicine, Research & Experimental

Dimethylarginines as Risk Markers of Atherosclerosis and Chronic Kidney Disease in Children with Nephrotic Syndrome

Lidia Hyla-Klekot et al.

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2015)

Review Biochemistry & Molecular Biology

Restoration of Asymmetric Dimethylarginine-Nitric Oxide Balance to Prevent the Development of Hypertension

You-Lin Tain et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)

Article Cell Biology

L-Arginine/NO Pathway Is Altered in Children with Haemolytic-Uraemic Syndrome (HUS)

Nele Kirsten Kanzelmeyer et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)

Review Urology & Nephrology

Dimethylarginines ADMA and SDMA: The Real Water-Soluble Small Toxins?

Eva Schepers et al.

SEMINARS IN NEPHROLOGY (2014)

Article Medical Laboratory Technology

Metformin reduces asymmetric dimethylarginine Mad and prevents hypertension in spontaneously hypertensive rats

Chih-Min Tsai et al.

TRANSLATIONAL RESEARCH (2014)

Article Biotechnology & Applied Microbiology

N-Acetylcysteine Prevents Hypertension via Regulation of the ADMA-DDAH Pathway in Young Spontaneously Hypertensive Rats

Nai-Chia Fan et al.

BIOMED RESEARCH INTERNATIONAL (2013)

Article Peripheral Vascular Disease

Urinary arginine methylation index associated with ambulatory blood pressure abnormalities in children with chronic kidney disease

Hsuan-Chang Kuo et al.

JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2012)

Article Cardiac & Cardiovascular Systems

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice

Giovanni Li Volti et al.

CARDIOVASCULAR DIABETOLOGY (2011)

Article Urology & Nephrology

Inflammation and Asymmetric Dimethylarginine for Predicting Death and Cardiovascular Events in ESRD Patients

Giovanni Tripepi et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)

Article Urology & Nephrology

Symmetric Dimethylarginine as a Proinflammatory Agent in Chronic Kidney Disease

Eva Schepers et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)

Article Pharmacology & Pharmacy

Aliskiren prevents hypertension and reduces asymmetric dimethylarginine in young spontaneously hypertensive rats

You-Lin Tain et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2011)

Review Medicine, General & Internal

Asymmetric Dimethylarginine: Clinical Applications in Pediatric Medicine

You-Lin Tain et al.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2011)

Review Biotechnology & Applied Microbiology

The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis

James Leiper et al.

NATURE REVIEWS DRUG DISCOVERY (2011)

Article Medical Laboratory Technology

Distribution of Asymmetric Dimethylarginine among 980 Healthy, Older Adults of Different Ethnicities

Karsten Sydow et al.

CLINICAL CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

Melatonin blocks oxidative stress-induced increased asymmetric dimethylarginine

You-Lin Tain et al.

FREE RADICAL BIOLOGY AND MEDICINE (2010)

Article Pediatrics

Bile duct ligation in developing rats: temporal progression of liver, kidney, and brain damage

Jiunn-Ming Sheen et al.

JOURNAL OF PEDIATRIC SURGERY (2010)

Article Endocrinology & Metabolism

Melatonin prevents increased asymmetric dimethylarginine in young rats with bile duct ligation

You-Lin Tain et al.

JOURNAL OF PINEAL RESEARCH (2010)

Review Biochemistry & Molecular Biology

Dimethylarginine dimethylaminohydrolase regulation: a novel therapeutic target in cardiovascular disease

Carol Wadham et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)

Review Pharmacology & Pharmacy

Cellular ADMA: Regulation and action

Tom Teerlink et al.

PHARMACOLOGICAL RESEARCH (2009)

Review Urology & Nephrology

Asymmetrical dimethylarginine in renal disease: Limits of variation or variation limits?

Johannes Jacobi et al.

AMERICAN JOURNAL OF NEPHROLOGY (2008)

Review Cardiac & Cardiovascular Systems

Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems

Fredrik Palm et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)

Review Endocrinology & Metabolism

Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism

David E. L. Wilcken et al.

MOLECULAR GENETICS AND METABOLISM (2007)

Review Pharmacology & Pharmacy

The L-arginine paradox:: Importance of the L-arginine/asymmetrical dimethylarginine ratio

Stefanie M. Bode-Boeger et al.

PHARMACOLOGY & THERAPEUTICS (2007)

Review Biochemical Research Methods

An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: Methodological considerations

John D. Horowitz et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)

Article Urology & Nephrology

The past, presence and future of ADMA in nephrology

Jan T. Kielstein et al.

NEPHROLOGIE & THERAPEUTIQUE (2007)

Article Medical Laboratory Technology

Determination of asymmetric dimethylarginine:: Liquid chromatography-mass spectrometry or ELISA?

J Martens-Lobenhoffer et al.

CLINICAL CHEMISTRY (2005)

Article Medical Laboratory Technology

Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay

F Schulze et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2004)

Review Urology & Nephrology

Review on uremic toxins:: Classification, concentration, and interindividual variability

R Vanholder et al.

KIDNEY INTERNATIONAL (2003)

Article Peripheral Vascular Disease

ADMA and oxidative stress

K Sydow et al.

ATHEROSCLEROSIS SUPPLEMENTS (2003)

Review Hematology

Does ADMA cause endothelial dysfunction?

JP Cooke

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)